Back to search
FDAFDA · Food and drugs·Recall number D-1431-2019

Pramipexole Dihydrochloride Tablets, 0.125 mg, 30 Tablets (6 tablets per blister card), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217 NDC Blister Card: 68084-793-95; NDC Carton: 68084-793-25

Published July 3, 2019 · Recall initiated: May 13, 2019

Summary

FDA records drug Class II recall D-1431-2019, published July 3, 2019 and initiated May 13, 2019. Recalling firm: American Health Packaging; Status: Terminated; Reported quantity: 3,015 cartons; Lot: Lot, expiry: Lot 179049, exp 12/31/2019; Lot 182571, exp 8/31/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

GMP Deviations; possible cross contamination of product due to cleaning procedure failure.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
American Health Packaging
Distributor
Nationwide USA
Lot
Lot, expiry: Lot 179049, exp 12/31/2019; Lot 182571, exp 8/31/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pramipexole Dihydrochloride Tablets, 0.125 mg, 30 Tablets (6 tablets per blister card), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217 NDC Blister Card: 68084-793-95; NDC Carton: 68084-793-25 recalled?

Yes. FDA published recall D-1431-2019 on July 3, 2019. Reported hazard: GMP Deviations; possible cross contamination of product due to cleaning procedure failure.

What should I do if I have this product?

Voluntary: Firm initiated · Letter